Mono Pharmacare
add_icon

Mono Pharmacare

11.40
-0.60
(-5.00%)
Market Cap
20.14 Cr
PE Ratio
6.82
Volume
4,000.00
Day High - Low
11.45 - 11.40
52W High-Low
27.90 - 9.45
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
20.14 Cr
EPS
1.75
PE Ratio
6.82
PB Ratio
0.68
Book Value
17.66
EBITDA
8.60
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
9.94
Debt to Equity
1.60
Forecast For
Actual

Company News

View All News
Caret
neutral
Mono Pharmacare Limited filed its SDD compliance certificate for FY26, confirming full adherence to SEBI PIT Regulations with no non-compliance reported.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,788.50
#1 4,29,121.06
37.31
#1 58,220.10
6.38
#1 11,565
25.80
44.37
6,576.50
1,74,585.41
67.49
10,560.00
8.73
2,520
13.44
46.75
4,368.50
1,47,849.89
68.30
13,753.00
19.18
2,028
-26.91
50.11
1,375.20
1,11,086.00
28.84
27,711.70
-2.46
3,783
-55.32
52.65
1,076.60
1,08,331.15
21.16
26,719.70
13.65
5,242
7.82
68.91
1,263.30
1,05,440.45
25.59
33,593.30
-0.44
3,998
-86.05
41.47
2,261.20
1,03,346.61
#1 19.21
27,487.50
19.98
5,345
#1 87.72
45.17
2,369.50
97,814.16
48.97
14,277.60
12.03
1,750
31.75
50.42
1,440.40
83,658.67
23.70
33,384.70
3.21
3,376
1.99
48.90
1,394.30
75,272.20
83.88
6,812.90
#1 21.03
884
21.18
76.00
Growth Rate
Revenue Growth
38.32 %
Net Income Growth
24.00 %
Cash Flow Change
50.97 %
ROE
13.73 %
ROCE
6.39 %
EBITDA Margin (Avg.)
-3.05 %

Yearly Financial Results

Annual Financials
2023
2024
2025
TTM
Revenue
27
122
169
0
Expenses
26
116
161
0
EBITDA
2
6
9
0
Operating Profit %
6 %
5 %
5 %
0 %
Depreciation
0
0
0
0
Interest
1
3
4
0
Profit Before Tax
1
3
5
0
Tax
0
1
1
0
Net Profit
1
3
3
0
EPS in ₹
0.71
1.59
1.75
0.00

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
63
81
110
Fixed Assets
1
1
1
Current Assets
61
80
109
Capital Work in Progress
0
0
0
Investments
0
0
0
Other Assets
62
80
109
Total Equity & Liabilities
63
81
110
Current Liabilities
31
36
53
Non Current Liabilities
18
17
26
Total Equity
13
28
31
Reserve & Surplus
1
10
14
Share Capital
12
18
18

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
0
-0
0
Investing Activities
-1
0
-0
Operating Activities
-28
-9
-4
Financing Activities
30
8
5

Share Holding

% Holding
Apr 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Sept 2024
Mar 2025
Sept 2025
Promoter
81.03 %
81.03 %
56.72 %
56.72 %
56.72 %
56.72 %
56.72 %
56.72 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
38.13 %
37.21 %
36.69 %
35.27 %
35.60 %
34.48 %
Others
18.97 %
18.97 %
5.14 %
6.07 %
6.59 %
8.01 %
7.68 %
8.80 %
No of Share Holders
17
17
972
528
418
463
478
514

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 35.75 38.80
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 35.80 35.00
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 24.10 26.95
29 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Nov 2025 20.00 22.05
30 Apr 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
30 Apr 2026 11.15 13.25

Technical Indicators

RSI(14)
Neutral
47.52
ATR(14)
Less Volatile
0.61
STOCH(9,6)
Neutral
45.00
STOCH RSI(14)
Neutral
42.06
MACD(12,26)
Bearish
-0.07
ADX(14)
Weak Trend
15.91
UO(9)
Bearish
51.75
ROC(12)
Downtrend And Accelerating
-9.43
WillR(14)
Neutral
-59.52